Antiviral Drugs - Malawi

Malawi

In Malawi, the revenue in the Antiviral Drugs market is estimated to reach US$3.29m by 2024.
It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 1.13%, leading to a market volume of US$3.48m by 2029.
When compared globally, United States is anticipated to generate the highest revenue of US$30,640.00m in 2024.
Malawi is witnessing a growing demand for antiviral drugs as the country battles against the spread of infectious diseases.

Key regions: Brazil, India, Australia, United States, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

Antiviral drugs have been in high demand worldwide since the outbreak of the COVID-19 pandemic. Malawi, a small landlocked country in southeastern Africa, is no exception to this trend.

Customer preferences: In Malawi, the demand for antiviral drugs has been driven by the increasing prevalence of viral diseases such as HIV/AIDS, hepatitis, and influenza. The country has a high burden of HIV/AIDS, with an estimated 9.2% of the adult population living with the disease. This has led to a significant demand for antiretroviral therapy (ART) drugs, which are a type of antiviral medication used to treat HIV/AIDS. Additionally, Malawi experiences seasonal influenza outbreaks, which have further fueled the demand for antiviral drugs.

Trends in the market: The antiviral drugs market in Malawi has been growing steadily over the past few years, driven by the increasing prevalence of viral diseases in the country. The market is expected to continue growing in the coming years, as the government and international organizations continue to invest in improving access to healthcare and antiviral drugs in the country. Additionally, the COVID-19 pandemic has led to a surge in demand for antiviral drugs worldwide, which is likely to have a positive impact on the market in Malawi as well.

Local special circumstances: Malawi is one of the poorest countries in the world, with a GDP per capita of just $394 in 2020. This has led to significant challenges in accessing healthcare and medication for many Malawians, particularly those living in rural areas. The government and international organizations have been working to address these challenges by investing in healthcare infrastructure, training healthcare workers, and improving access to medication through initiatives such as the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Underlying macroeconomic factors: The antiviral drugs market in Malawi is influenced by a range of macroeconomic factors, including government policies, international aid, and global market trends. The government plays a significant role in regulating the pharmaceutical industry and ensuring that medication is affordable and accessible to all Malawians. International aid from organizations such as the Global Fund also plays a crucial role in improving access to healthcare and medication in the country. Finally, global market trends and the COVID-19 pandemic have had a significant impact on the antiviral drugs market in Malawi, highlighting the importance of the country's integration into the global economy.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.